A new startup is making a bold move in the world of obesity drug development: Its not working with the GLP-1 target that has taken the world by storm. Just a few years ago, the term GLP-1 would have…
STAT
A new biotech startup tries to tackle obesity, but not in the way you might expect
Read full article at STAT
Disclaimer: This article summary is sourced from STAT. HealthRankings provides this for informational purposes only. Always consult a qualified healthcare provider before making medical decisions.
More health news
The Washington Post
U.S. measles cases hit 35-year record with months left in 2026
Yesterday
Fox News
Rabid bat found near zoo restaurant sparks urgent public health warning: 'Extremely serious'
Yesterday
KOCO Oklahoma City
Oklahoma cyclosporiasis cases rise to 172 with 12 hospitalizations, OSDH says
Yesterday:max_bytes(150000):strip_icc()/GettyImages-2158320544-1ceb5a9c008648af9f994a05a4c3f802.jpg)
Verywellhealth.com